Target Name: LOC643441
NCBI ID: G643441
Review Report on LOC643441 Target / Biomarker Content of Review Report on LOC643441 Target / Biomarker
LOC643441
Other Name(s): Uncharacterized LOC643441 | uncharacterized LOC643441

LOC643441: A Protein with Potential as A Drug Target Or Biomarker

LOC643441 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the LOC643441 family, which is characterized by the presence of a unique transmembrane domain and a cytoplasmic tail. LOC643441 is unique among its family members because of its ability to form inclusion bodies, which are clusters of protein molecules that can interact with and influence one another.

The study of LOC643441 has been primarily focused on its potential role in drug development and as a biomarker for various diseases. Several studies have demonstrated that LOC643441 is involved in a variety of cellular processes, including cell signaling, DNA replication, and metabolism. Additionally, LOC643441 has been shown to play a role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the main potential uses for LOC643441 as a drug target is its ability to modulate the activity of other proteins. This is done by LOC643441 forming inclusion bodies with other proteins, which can then interact with those proteins and alter their activity. For example, LOC643441 has been shown to form inclusion bodies with the protein PDGF-BB, which is involved in cell signaling and growth. By interacting with PDGF-BB, LOC643441 has been shown to inhibit its activity, which could potentially be used as a therapeutic approach for diseases such as cancer or neurodegenerative disorders.

Another potential use for LOC643441 as a drug target is its role in the development of neurodegenerative diseases. LOC643441 has been shown to be involved in the development of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles, which are thought to contribute to the symptoms of these diseases. LOC643441 has been shown to play a role in the development of neurofibrillary tangles and has also been shown to interact with the protein tau, which is involved in the development of neurodegenerative diseases.

In addition to its potential as a drug target, LOC643441 has also been shown to be a valuable biomarker for several diseases. For example, LOC643441 has been shown to be involved in the development of cancer, and has been used as a biomarker for the disease. Additionally, LOC643441 has been shown to be involved in the development of neurodegenerative diseases, and has been used as a biomarker for these conditions.

Overall, LOC643441 is a protein that has the potential to be a drug target or a biomarker for several diseases. Further research is needed to fully understand its role in these processes and to develop effective therapies based on its properties.

Protein Name: Uncharacterized LOC643441

The "LOC643441 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC643441 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC643454 | LOC643763 | LOC643855 | LOC643923 | LOC644006 | LOC644083 | LOC644086 | LOC644189 | LOC644215 | LOC644277 | LOC644525 | LOC644584 | LOC644634 | LOC644656 | LOC644662 | LOC644669 | LOC644893 | LOC644936 | LOC645086 | LOC645181 | LOC645188 | LOC645266 | LOC645468 | LOC645503 | LOC645967 | LOC646044 | LOC646214 | LOC646358 | LOC646471 | LOC646674 | LOC646736 | LOC646762 | LOC646813 | LOC646836 | LOC646853 | LOC646903 | LOC646934 | LOC646970 | LOC647115 | LOC647132 | LOC647481 | LOC649133 | LOC650157 | LOC650226 | LOC651536 | LOC652276 | LOC652608 | LOC653303 | LOC653503 | LOC653513 | LOC653631 | LOC653653 | LOC653698 | LOC727751 | LOC728024 | LOC728098 | LOC728114 | LOC728138 | LOC728376 | LOC728392 | LOC728417 | LOC728485 | LOC728554 | LOC728660 | LOC728688 | LOC728715 | LOC728739 | LOC728743 | LOC728877 | LOC728989 | LOC729086 | LOC729164 | LOC729173 | LOC729218 | LOC729296 | LOC729444 | LOC729609 | LOC729683 | LOC729732 | LOC729737 | LOC729815 | LOC729870 | LOC729887 | LOC729966 | LOC729973 | LOC730098 | LOC730100 | LOC730101 | LOC730183 | LOC730234 | LOC730338 | LOC730668 | LOC90246 | LOC91450 | LOC93429 | LOC93463 | LOC93622 | LOH12CR2 | Long intergenic non-protein coding RNA 1336 | Long intergenic non-protein coding RNA 205